ARCHIVES

Micafungin Bests Fluconazole In Phase III Antifungal Trial

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

April 29, 1988

Harvard’s DePinho Becomes Finalist at MD Anderson

May 20, 2011

In Brief: Community Outreach Planning Grants Still Open; Study Section Meetings May Be Opened By Courts

October 18, 1974

Radiation Therapy Combination Better For Treating Cancer Spread To Brain

May 28, 2004

Surgeons, Intramural Scientists Concerned About Representation

November 26, 1976

In Brief: Cancer Act renewal, Appropriations Bill Caught In Squeeze Between Conventions

August 1, 1980